Zurich-based MedTech startup KOVE Medical has closed a €1.7 million (CHF 1.6 million) to develop an implantable medical device designed to reduce the risk of preterm birth following foetal surgery, with the fresh capital set to support the company as it progresses towards First-in-Human studies. The round was backed by a syndicate of angel investors. […] The post Reducing preterm birth risks in...